An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis

NCT03664960 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Eosinophilic Gastritis
Eosinophilic Gastroenteritis
Eosinophilic Duodenitis

Interventions

DRUG: AK002

Sponsor

Allakos Inc.